Coty Inc.: Form 10-Q for the period ended Mar 31, 2020
Filed with the SEC on May 11, 2020 and accepted by EDGAR at May 11, 2020, 17:07 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-01-01 to 2020-03-31 | $1.53bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2019-07-01 to 2020-03-31 | $5.82bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2020-01-01 to 2020-03-31 | $617.1m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2019-07-01 to 2020-03-31 | $2.21bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2020-01-01 to 2020-03-31 | $910.9m | us-gaap:GrossProfit |
| Gross profit | 9 months2019-07-01 to 2020-03-31 | $3.60bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2020-01-01 to 2020-03-31 | $999.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2019-07-01 to 2020-03-31 | $3.27bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2020-01-01 to 2020-03-31 | −$258.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2019-07-01 to 2020-03-31 | −$97.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2020-01-01 to 2020-03-31 | $68.7m | us-gaap:InterestExpense |
| Interest expense | 9 months2019-07-01 to 2020-03-31 | $210.5m | us-gaap:InterestExpense |
| Income tax | 3 months2020-01-01 to 2020-03-31 | −$68.5m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2019-07-01 to 2020-03-31 | −$99.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-01-01 to 2020-03-31 | −$271.6m | us-gaap:NetIncomeLoss |
| Net income | 9 months2019-07-01 to 2020-03-31 | −$240.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-01-01 to 2020-03-31 | −$0.36 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2019-07-01 to 2020-03-31 | −$0.32 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-01-01 to 2020-03-31 | −$0.36 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2019-07-01 to 2020-03-31 | −$0.32 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-01-01 to 2020-03-31 | 760,800,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2019-07-01 to 2020-03-31 | 757,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2019-07-01 to 2020-03-31 | $204.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2019-07-01 to 2020-03-31 | $206.4m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 9 months2019-07-01 to 2020-03-31 | $195.2m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2019-07-01 to 2020-03-31 | $4.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2020-03-31 | $1.28bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-03-31 | $3.67bn | us-gaap:AssetsCurrent |
| Total assets | At period end2020-03-31 | $18.31bn | us-gaap:Assets |
| Current liabilities | At period end2020-03-31 | $3.09bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-03-31 | $14.25bn | us-gaap:Liabilities |
| Long-term debt | At period end2020-03-31 | $9.17bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2020-03-31 | $185.9m | us-gaap:DebtCurrent |
| Short-term borrowings | At period end2020-03-31 | $100.0k | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2020-03-31 | $3.73bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001024305-20-000049. Last ingested by Listed: Nov 11, 2026, 03:30 ET. Listed shows no prices and gives no investment advice.